Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Experimental Mammary Neoplasms

triethylenemelamine has been researched along with Experimental Mammary Neoplasms in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DUNNING, WF1
CURTIS, MR1
Tannock, IF1
Marshall, N1
van Putten, LM1

Other Studies

2 other studies available for triethylenemelamine and Experimental Mammary Neoplasms

ArticleYear
COMPARATIVE RESPONSE OF A SPECTRUM OF TRANSPLANTABLE RAT NEOPLASMS TO NITROGEN MUSTARD, TRIETHYLENEMELAMINE, AND A GROUP OF BENZALDEHYDE MUSTARD DERIVATIVES.
    Cancer chemotherapy reports, 1964, Volume: 36

    Topics: Animals; Benzaldehydes; Carcinoma, Bronchogenic; Carcinoma, Hepatocellular; Female; Humans; Injectio

1964
An attempt at selective chemotherapy of hypoxic cells: triethylenemelamine and irradiation of a C3H mouse mammary tumour.
    European journal of cancer, 1972, Volume: 8, Issue:5

    Topics: Animals; Female; Glucose; Hematopoietic Stem Cells; Hypoxia; Mammary Neoplasms, Experimental; Mice;

1972